Cerebral Infarction  >>  Cerebrolysin (porcine brain-derived proteolytic peptide fraction)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
CASTA, NCT00868283: The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

Completed
4
1071
RoW
Cerebrolysin, 0.9% Saline Solution, NaCl
Ever Neuro Pharma GmbH, Excel PharmaStudies, Inc., idv Datenanalyse und Versuchsplanung
Ischemic Stroke
10/10
02/11

Download Options